Results 141 to 150 of about 15,403 (210)

Simultaneous Treatment of 5-Aminosalicylic Acid and Treadmill Exercise More Effectively Improves Ulcerative Colitis in Mice. [PDF]

Int J Mol Sci
Jin JJ, Ko IG, Hwang L, Kim SH, Jee YS, Jeon H, Park SB, Jeon JW.   +7 more
europepmc   +1 more source

5-Aminosalicylic Acid-Induced Liver Injury in a Patient with Ulcerative Colitis: A Case Report. [PDF]

Case Rep Gastroenterol
Watanabe A, Nishida T, Osugi N, Kitanaka T, Minoura Y, Okabe S, Sakamoto N, Fujii Y, Sugimoto A, Nakamatsu D, Matsumoto K, Yamamoto M, Adachi S, Fukui K.   +13 more
europepmc   +1 more source

Sustained release of 5-aminosalicylic acid from azoreductase-responsive polymeric prodrugs for prolonged colon-targeted colitis therapy. [PDF]

J Nanobiotechnology
Tang S, Wang W, Wang Y, Gao Y, Dai K, Zhang W, Wu X, Yuan X, Jin C, Zan X, Zhu L, Geng W.   +11 more
europepmc   +1 more source

Synthesis and Bioactive Properties of the Novel Coloured Compound Obtained via the Laccase-Mediated Transformation of 5-Aminosalicylic Acid. [PDF]

Molecules
Polak J, Grąz M, Szałapata K, Kapral-Piotrowska J, Wlizło K, Polak M, Jarosz-Wilkołazka A.   +6 more
europepmc   +1 more source

Drug-induced Interstitial Nephritis in a Patient with Ulcerative Colitis Treated with 5-Aminosalicylic Acid. [PDF]

Intern Med
Hayashi D, Nishida T, Osugi N, Kusunoki Y, Okabe S, Fujii Y, Nakamatsu D, Matsumoto K, Yamamoto M, Fukui K.   +9 more
europepmc   +1 more source

Efficacy and safety of Chinese patent medicine combined with 5-aminosalicylic acid for patients with ulcerative colitis: A network meta-analysis of randomized controlled trials. [PDF]

Heliyon
Zhang M, Su Y, Gao Q, Zhou M, Xing Y, Chen Z, Liu X, Li Z, Geng X, Cao G, Zhang H, Wei S.   +11 more
europepmc   +1 more source

Immunogenicity of Hepatitis B Vaccination in Patients with Ulcerative Colitis on Infliximab Is Attenuated Compared to Those on 5-Aminosalicylic Acid Therapies: A Prospective Observational Study. [PDF]

Vaccines (Basel)
Shehab M, Alrashed F, Alyaseen M, Safar Z, Adekunle T, Alfadhli A, Bessissow T.   +6 more
europepmc   +1 more source

Analysis of the Medication Persistence Rate for and Adherence to Oral 5-Aminosalicylic Acid Preparations in Japanese Patients with Ulcerative Colitis: Study Using a Nationwide Claims Database.

Digestion
Ota T, Takebe T, Shimizu Y, Orido T, Tanaka H, Nakamura S.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Disposition of 5-Aminosalicylic Acid by 5-Aminosalicylic Acid-Delivering Compounds

Scandinavian Journal of Gastroenterology, 1988
The disposition of 5-aminosalicylic acid (5-ASA) from 5-ASA-delivering drugs was studied in eight healthy volunteers. Time-related urinary excretion and faecal excretion of 5-ASA and acetyl-5-ASA were measured after a single oral dose of the azo compounds sulphasalazine and olsalazine, of the slow-release compounds Pentasa, Asacol, and Salofalk, and of
J H Van Tongeren
exaly   +4 more sources